AnswerMyQ Featured in Forbes on Patient Readiness and Governed AI in Eye Care
Founder and CEO Phil Alexander joins Dr. Jason Lake of PERC Alliance in a Forbes feature on how governed AI prepares patients before the exam, turning the visit into a conversation about confirmation, not explanation.
AnswerMyQ, the Governed AI Knowledge Platform for the Enterprise, was featured in Forbes on July 6, 2026, in an article by contributor Jeff Fromm on patient readiness in independent eye care.
The piece, built around a conversation with AnswerMyQ founder and CEO Phil Alexander and Dr. Jason Lake, General Manager of PERC Alliance, points to a problem few in the industry talk about: patients arrive at their once-a-year, 45-minute exam unprepared. Time that should go to personalized care gets spent explaining the basics, and more than a third of patients leave without buying eyewear.
There's a competitive edge underneath all this too. The big retail chains, LensCrafters, Warby Parker, and America's Best, stay in front of their customers all year through apps, email, and online tools. Most independent practices don't. What the independent has that the chains can't copy is trust, a real doctor the patient actually believes. The catch is that the trust mostly goes unused in the 364 days between visits.
The answer isn't a longer visit. It's a better-prepared patient. When someone spends a few minutes with a governed AI tool before an appointment, thinking through how they use their vision and what has been frustrating them, they arrive with context and specific questions. The visit becomes about confirmation rather than explanation.
Alexander's point comes down to governance. Patients are already using consumer AI before their appointments. The problem isn't that they use it, it's that a general chatbot has no idea what's clinically right, what a given practice actually stocks, or where to send the patient next. An AI built and configured for that specific practice fixes that. It runs on approved product and clinical knowledge, and it steers the patient toward the next step.
In eye care, that tool sits on the practice's own website and takes the name of the practice's own doctor. Patients at Dr. Rivera's office see Ask Dr. Rivera. On this page we call it Ask Dr. Name as a stand-in for whichever doctor's name a practice uses.
"Patients are simply not ready when they come in. If we can improve patient readiness, everything changes."
Phil Alexander, Founder and CEO of AnswerMyQ
AnswerMyQ is the Governed AI Knowledge Platform for the Enterprise. It enforces policy before response and delivers source-cited, role-aware answers. In eye care, that means governed AI that stays with patients through the 364 days between visits, grounded in the products a practice carries and the clinical context their doctor can act on, and always pointing to the next step. It's built for manufacturers and independent practices that want answers their patients can trust. Learn more at answermyq.com.
AnswerMyQ is the Governed AI Knowledge Platform for the Enterprise. In eye care, that means a purpose-built AI that lives on an independent practice's website and gets patients ready before their appointment, grounded in the products that practice carries and the clinical context their doctor can act on. The patient shows up ready, and the visit becomes a confirmation instead of an explanation.
AnswerMyQ was featured in Forbes in July 2026, in an article by Jeff Fromm on patient readiness in independent eye care, featuring founder and CEO Phil Alexander and Dr. Jason Lake of PERC Alliance.
Ask Dr. Name is AnswerMyQ's governed AI for eye care. It sits on an independent practice's website under that practice's own doctor's name, so Dr. Rivera's patients see Ask Dr. Rivera. It answers patient questions before the visit, grounded in the products that practice carries and the clinical context their doctor can act on.
The practice doesn't pay for it. Ask Dr. Name goes in through their marketing partner and is funded by manufacturers like Essilor through co-op marketing programs. The practice gets a governed AI on its website, Essilor gets its products in front of patients while they're still forming preferences, and the practice pays nothing.
Governance. A generic chatbot just answers from whatever it was trained on, with no clinical accuracy, no product specificity, and no idea what the patient's own practice carries. Ask Dr. Name is set up around that practice's actual catalog, runs on manufacturer-approved product knowledge, and always points the patient to one clear next step: booking with their doctor.